Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Richard S. Lindahl files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Donald W. Degolyer - $318K of EBS open-market activity in the last 12 months
- Coleen Glessner - $306K of EBS open-market activity in the last 12 months
- Sujata Tyagi Dayal - $201K of EBS open-market activity in the last 12 months
- Kathryn C. Zoon - $144K of EBS open-market activity in the last 12 months
- Keith Katkin - $128K of EBS open-market activity in the last 12 months
- Paul Anthony Williams - $59K of EBS open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Richard S. Lindahl?
Richard S. Lindahl is a corporate insider, tracked as EVP, Chief Financial Officer of Emergent BioSolutions Inc. (EBS). InsiderAlpha holds 9 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Richard S. Lindahl submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Richard S. Lindahl's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Richard S. Lindahl and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
